Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2019 Annual Meeting | Resident and Fellow Conversation

Wednesday 05/08/19
11:00 AM - 11:30 AM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Hubs (Navigating Your Career)
Abhimanyu Mahajan, MD, MHS, FÂé¶¹´«Ã½Ó³»­
Experiential Learning Area, General Neurology
No CME available
Interpersonal and Communication Skills, Professionalism
Introductory
Academic
Fellow, Resident
Audience Participation

Program Materials Program Evaluations

Event Timeline
11:00 AM - 11:30 PM EDT Speaker Resident and Fellow Conversation
Abhimanyu Mahajan, MD, MHS, FÂé¶¹´«Ã½Ó³»­
Faculty Disclosures
Abhimanyu Mahajan, MD, MHS, FÂé¶¹´«Ã½Ó³»­ Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima Therapeutics, Inc.. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Mahajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adaptive Biosciences . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement disorders clinical practice. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Texas Alzheimer's Research And Care Consortium .